GlassScriptPhysician profile
Kathryn E Miller
NPI 1346581634
$7,248.59
in general payments reported to CMS, 2019-2025
24 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $334 · 2021: $665 · 2022: $1,443 · 2023: $1,044 · 2024: $1,405 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,989 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,989.23 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $945.48 | 2022-2025 | |
| New World Medical,INC. | $883.34 | 2022-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Johnson & Johnson Surgical Vision, INC. | $871.17 | 2019-2025 | Veritas Vision System, Tecnis Simplicity, Tecnis Iol |
| Glaukos Corporation | $833.54 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idose, Idosetr |
| Mallinckrodt Hospital Products INC. | $688.42 | 2023-2025 | Acthar |
| Alcon Vision LLC | $687.53 | 2019-2024 | Clareon, Rocklatan |
| Sight Sciences, INC. | $461.20 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $379.35 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $279.24 | 2022-2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Bausch & Lomb Americas INC. | $231.72 | 2022-2024 | Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.35 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $163.32 | 2019 | |
| Ocular Therapeutix, INC. | $122.55 | 2023 | Dextenza |
| Apellis Pharmaceuticals, INC. | $117.73 | 2025 | Syfovre |
| Quidel Corporation | $89.38 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $71.68 | 2023 | Tearlab Osmolarity System |
| Ani Pharmaceuticals, INC. | $48.18 | 2024 | Purified Cortrophin Gel |
| Nuvasive Specialized Orthopedics, INC. | $41.73 | 2022 | |
| Horizon Therapeutics Plc | $23.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.75 | 2023 | |
| Shire North American Group INC | $19.66 | 2019 | |
| Alcon Research LLC | $17.82 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.44 | 2021 | |
| Lombart Brothers, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.